Prothena Corporation plc
PRTA
$8.54+1.91%
End of day · as of Oct 1, 2026, 11:01 PM ET
Mkt cap
$460.18M
EV/Sales
15.8
P/E ratio
N/A
FY2025 Revenue
$9.68M
EPS (TTM)
$-0.82
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-2520.57%
Beta
-0.32
Div yield
N/A
Sector
Healthcare
Prothena Corporation plc (PRTA) is a biotechnology company listed on US.
Latest reported PRTA revenue for 2025-12-31 was $9.7M. Net income was -$244.1M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. PRTA currently screens at market cap $460.2M.
Use this PRTA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PRTA income, balance, and cash tables.
Prothena Corporation plc (PRTA) is a biotechnology company in the Healthcare sector.
Latest cached Prothena Corporation plc (PRTA) revenue for Dec 31, 2025 was $9.7M. Net income was -$244.1M. Statements: https://lician.com/financials/prta
Prothena Corporation plc (PRTA) market capitalization is $460.2M on the latest cached snapshot.
Prothena Corporation plc (PRTA) cached previous close $8.38; day range $8.35 – $8.58; volume 456,927. Session quote: https://lician.com/quote/prta
Prothena Corporation plc (PRTA) latest cached earnings event is "PRTA earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PRTA filing is 8-K · Oct 2, 2026. Filings: https://lician.com/sec/prta